Technical Analysis for HQL - H&Q Life Sciences Investors

Grade Last Price % Change Price Change
B 15.55 0.06% 0.01
HQL closed up 0.06 percent on Friday, September 20, 2024, on 81 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Stochastic Sell Signal Bearish 0.06%
Pocket Pivot Bullish Swing Setup 0.06%
Upper Bollinger Band Walk Strength 0.06%
Gapped Up Strength 0.06%

   Recent Intraday Alerts

Alert Time
Rose Above Upper Bollinger Band about 11 hours ago
2x Volume Pace about 11 hours ago
1.5x Volume Pace about 11 hours ago
Upper Bollinger Band Resistance about 11 hours ago
Rose Above Previous Day's High about 11 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

H&Q Life Sciences Investors Description

H&Q Life Sciences Investors is a close ended equity mutual fund launched and managed by Hambrecht & Quist Capital Management, LLC. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating in the health technology and life sciences industries. It also invests in stocks of early and later stage financings of privately held companies, private placements by public companies. The fund invests in growth stocks of companies operating across all market capitalizations. It employs fundamental analysis with a focus on factors such as potential for above-average, long-term growth in revenues and earnings securities strong market position for their services or products, experienced business management, and, recognized technological expertise. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. H&Q Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.


Classification

Sector: Financial Services
Industry: Asset Management
Keywords: Stock Fund Business Management Health Technology Nasdaq Biotech Experienced Business Management

Is HQL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.684
52 Week Low 10.0622
Average Volume 98,250
200-Day Moving Average 13.29
50-Day Moving Average 14.96
20-Day Moving Average 15.16
10-Day Moving Average 15.27
Average True Range 0.23
RSI (14) 65.28
ADX 22.75
+DI 27.52
-DI 15.11
Chandelier Exit (Long, 3 ATRs) 15.00
Chandelier Exit (Short, 3 ATRs) 15.37
Upper Bollinger Bands 15.66
Lower Bollinger Band 14.65
Percent B (%b) 0.89
BandWidth 6.67
MACD Line 0.17
MACD Signal Line 0.13
MACD Histogram 0.0409
Fundamentals Value
Market Cap 416.6 Million
Num Shares 26.8 Million
EPS 0.79
Price-to-Earnings (P/E) Ratio 19.68
Price-to-Sales 107.46
Price-to-Book 0.92
PEG Ratio 0.00
Dividend 1.30
Dividend Yield 8.36%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.85
Resistance 3 (R3) 15.86 15.77 15.80
Resistance 2 (R2) 15.77 15.70 15.77 15.78
Resistance 1 (R1) 15.66 15.65 15.62 15.65 15.77
Pivot Point 15.57 15.57 15.55 15.57 15.57
Support 1 (S1) 15.46 15.50 15.42 15.45 15.33
Support 2 (S2) 15.37 15.45 15.37 15.32
Support 3 (S3) 15.26 15.37 15.30
Support 4 (S4) 15.25